(a) If any material change occurs in the facts set forth in the Schedule 13D required by Rule13d–1(a), including, but not limited to, any material increase or decrease in the percentage of the class beneficially owned, the person or persons who were required to file the statement shall promptly file or cause to be filed with the Commission an amendment disclosing that change.
An acquisition or disposition of beneficial ownership of securities in an amount equal to one percent or more of the class of securities shall be deemed “material” for purposes of this section; acquisitions or dispositions of less than those amounts may be material, depending upon the facts and circumstances.
For complete statutory definitions and more information on the meaning of Responsible Party and sponsor, see the Elaboration of Definitions of Responsible Party and Applicable Clinical Trial (PDF) and the Responsible Party data element on Clinical
Registration is required for trials that meet the FDAAA 801 definition of an "applicable clinical trial" and were either initiated after September 27, 2007, or initiated on or before that date and were still ongoing as of December 26, 2007.
A firm (and in some cases its "controlling persons") will likely have a Section 13 reporting obligation if, as of December 31, 2012, the firm: In addition, Section 16 of the Exchange Act imposes a reporting obligation on certain persons considered "insiders" of a company that has a class of equity securities registered under Section 12 of the Exchange Act.
Such insiders may be liable for short swing profits – i.e., profits made from sales and purchases of the company's securities within a six-month time period.
Statements on Standards for Attestation Engagements (SSAEs) are issued by senior technical bodies of the AICPA designated to issue pronouncements on attestation matters.
However, to fully support the latest version of a required component, you should apply the latest update for Microsoft Dynamics 365.
SSAE Hierarchy This section identifies the attestation standard released by the AICPA, as well as other attestation guidance, that practitioners need to comply with or be aware of when conducting attest engagements.
An Examination of an Entity’s Internal Control Over Financial Reporting That Is Integrated With an Audit of Its Financial Statements This section establishes requirements and provides guidance applicable to practitioners performing an examination of the design and operating effectiveness of an entity’s internal control over financial reporting that is integrated with an audit of financial statements.
Schedule 13D is a far more detailed and burdensome form than Schedule 13G; however, Schedule 13G may only be used by certain defined persons.
If Schedule 13G is not available, a person must report on Schedule 13D.